Program: Oral and Poster Abstracts
Monday, December 12, 2011: 7:00 AM-8:30 AM
Ballroom 20A (San Diego Convention Center)
Guillaume Cartron, MD, PhD, Hôpital Saint Eloi and Michael Millenson, MD, Fox Chase Cancer Center
Cartron: GSK: Honoraria; Roche: Consultancy, Honoraria; LFB: Honoraria.
Final Results of a Multicenter Phase II Trial with Translational Elements to Investigate the Possible Infective Causes of Ocular Adnexal Marginal Zone B-Cell Lymphoma (OAMZL) with Particular Reference to Chlamydia Species and the Efficacy of Doxycycline As First-Line Lymphoma Treatment (the IELSG#27 TRIAL)
See more of: Oral and Poster Abstracts
*signifies non-member of ASH